The diabetes diagnosis, treatment and drug delivery market is expected to reach a market value of €9.5 billion by 2022.

1. NOVO NORDISK LEAD
EUROPEAN DIABETES
DEVICE MARKET DUE TO
TECHNOLOGICAL
ADVANCEMENTS
IDATA RESEARCH INC.
AUGUST 2016
EUROPEAN MARKET REPORT SUITE FOR DIABETES DIAGNOSIS,
TREATMENT AND DRUG DELIVERY

2. IDATA RESEARCH INC.
€ 9. 5 BILLION
BY 2022
The diabetes diagnosis, treatment
and drug delivery market is
expected to reach a market value
of €9.5 billion by 2022.

3. IDATA RESEARCH INC.
TECHNOLOGICAL
ADVANCEMENTS
Market growth will be driven by the increasing prevalence of diabetes in Europe
and technological advancements made in certain segments, particularly insulin
pumps and continuous glucose monitoring (CGM). However, the recent influx of
inexpensive competitors in the test strip and pen needle segments has placed
downward pressure on the prices of these products and has resulted in market
value contractions despite growing volume in certain regions in Europe.

4. IDATA RESEARCH INC.
LEADING
COMPETITORSNovo Nordisk is the leading competitor in the European diabetes
diagnosis, treatment and drug delivery market. The company’s most
popular products include rapid-acting insulin analog NovoRapid®, long-
acting insulin analog Levemir® and premixed insulin analog NovoMix®.
Sanofi is the second leading competitor in the market. Sanofi recently
launched Toujeo®, an ultra-long-acting insulin analog that lasts up to 36
hours and only requires an injection once a day.

5. “ FAVORABLE REIMBURSEMENT
POLICIES AND TECHNOLOGICAL
INNOVATION RESULTS IN A
HIGH GROWTH TREND FOR PEN
NEEDLES AND INSULIN PUMPS. ”
IDATA RESEARCH INC.
- - KAMRAN ZAMANIAN ( IDATA RESEARCH INC. CEO)
“ WITH AN INCREASING NUMBER OF COMPETITORS PLANNING TO ENTER
THE MARKET IN THE NEAR FUTURE, IT IS EXPECTED THAT THIS TREND
WILL PREVAIL OVER THE FORECAST PERIOD AND CONTRIBUTE TO THE
GROWTH OF THE MARKET IN EUROPE. ”

6. VISIT
IDATARESEARCH. COM
FOR MORE INFORMATION
IDATA RESEARCH INC.
AUGUST 2016
EUROPEAN MARKET REPORT SUITE FOR DIABETES
DIAGNOSIS, TREATMENT AND DRUG DELIVERY